Scholar aims to reverse-engineer cancer with 3D tool

by Kim Horner,University of Texas at DallasDr. Chen Cao (center), assistant professor of bioengineering, is shown with some members of her lab, from left, biomedical engineering junior Namyuktha

Updated on: September 28,2024

Scholar aims to reverse-engineer cancer with 3D tool

by Kim Horner,University of Texas at DallasDr. Chen Cao (center), assistant professor of bioengineering, is shown with some members of her lab, from left, biomedical engineering junior Namyuktha

Updated on:September 28,2024

Research suggests a new approach for treatment-resistant breast cancers

by Louisiana State UniversityCB-103 shows synergy with paclitaxel and fulvestrant in breast cancer cell lines. TNBC (HCC1187) and ER+ BC (MCF-7) cells were treated with combinations of CB-103 (15

Updated on: February 18,2024

Research suggests a new approach for treatment-resistant breast cancers

by Louisiana State UniversityCB-103 shows synergy with paclitaxel and fulvestrant in breast cancer cell lines. TNBC (HCC1187) and ER+ BC (MCF-7) cells were treated with combinations of CB-103 (15

Updated on:February 18,2024

Researchers discuss reassessing COVID-19 precautions in 2023

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new editorial paper titled "Reassessing the risks and benefits of COVID-19 precautions in 2023" has been published inOncotarget

Updated on: January 30,2024

Researchers discuss reassessing COVID-19 precautions in 2023

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new editorial paper titled "Reassessing the risks and benefits of COVID-19 precautions in 2023" has been published inOncotarget

Updated on:January 30,2024

Scrapping England's cancer plan is 'a catastrophic decision that will cost lives' warn experts

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainThe UK government's proposal to roll England's long term plan for cancer into one strategy covering all major conditions, such a

Updated on: January 22,2024

Scrapping England's cancer plan is 'a catastrophic decision that will cost lives' warn experts

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainThe UK government's proposal to roll England's long term plan for cancer into one strategy covering all major conditions, such a

Updated on:January 22,2024

Team targets tumor suppressor to treat 'triple-negative' breast cancer

by University of Arizona Health SciencesAgnieszka Witkiewicz, MD and Erik Knudsen, PhD, UA Cancer Center. Credit: BioCommunications, Kris HanningA study by scientists at the University of Arizona Canc

Updated on: May 27,2024

Team targets tumor suppressor to treat 'triple-negative' breast cancer

by University of Arizona Health SciencesAgnieszka Witkiewicz, MD and Erik Knudsen, PhD, UA Cancer Center. Credit: BioCommunications, Kris HanningA study by scientists at the University of Arizona Canc

Updated on:May 27,2024

Researchers discover molecule that promotes production of cancer cells in triple-negative breast cancer

byHiroshima UniversityHiroshima University researchers found that AIbZIP is highly upregulated in triple negative breast cancer (TNBC). AIbZIP induces hyper proliferation of TNBC cells by promot

Updated on: March 30,2024

Researchers discover molecule that promotes production of cancer cells in triple-negative breast cancer

byHiroshima UniversityHiroshima University researchers found that AIbZIP is highly upregulated in triple negative breast cancer (TNBC). AIbZIP induces hyper proliferation of TNBC cells by promot

Updated on:March 30,2024

Using donor CAR T cells shows promise in treating myeloma patients in phase I trial

by Bob Yirka , Medical XpressCAR T Cell Concentrations Stratified by Response. (a) CAR T cell concentrations among ALLO-715 DL3 patients that received any fludarabine/cyclophosphamide/ALLO-647 (FCA) l

Updated on: February 03,2024

Using donor CAR T cells shows promise in treating myeloma patients in phase I trial

by Bob Yirka , Medical XpressCAR T Cell Concentrations Stratified by Response. (a) CAR T cell concentrations among ALLO-715 DL3 patients that received any fludarabine/cyclophosphamide/ALLO-647 (FCA) l

Updated on:February 03,2024

In situ, invasive melanoma diagnoses decreased in 2020

by Elana GotkineDuring 2020, there were decreases seen for in situ and invasive melanoma diagnoses, according to a research letter published online Sept. 6 inJAMA Dermatology.Daniel Y. Kim, from

Updated on: January 29,2024

In situ, invasive melanoma diagnoses decreased in 2020

by Elana GotkineDuring 2020, there were decreases seen for in situ and invasive melanoma diagnoses, according to a research letter published online Sept. 6 inJAMA Dermatology.Daniel Y. Kim, from

Updated on:January 29,2024

Lung cancer screening more cost effective when using risk model-based strategies, study shows

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainRisk model-based lung cancer screening strategies, which select individuals based on personal risk, are more co

Updated on: January 16,2024

Lung cancer screening more cost effective when using risk model-based strategies, study shows

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainRisk model-based lung cancer screening strategies, which select individuals based on personal risk, are more co

Updated on:January 16,2024

Race, insurance status linked to job loss after breast cancer

by Neil Schoenherr,Washington University in St. LouisCredit: Washington University in St. LouisJob loss following early-stage breast cancer diagnosis is associated with race and insurance status

Updated on: April 07,2024

Race, insurance status linked to job loss after breast cancer

by Neil Schoenherr,Washington University in St. LouisCredit: Washington University in St. LouisJob loss following early-stage breast cancer diagnosis is associated with race and insurance status

Updated on:April 07,2024

Study reveals somatic mutation profile of colorectal tumor with simultaneous APC and MLH1 germline mutations

by Zhao Weiwei; Hong Bo, Hefei Institutes of Physical Science, Chinese Academy of SciencesThe pedigree of the studied family, and hematoxylin-eosin staining of colorectal adenocarcinoma or adenomas in

Updated on: February 20,2024

Study reveals somatic mutation profile of colorectal tumor with simultaneous APC and MLH1 germline mutations

by Zhao Weiwei; Hong Bo, Hefei Institutes of Physical Science, Chinese Academy of SciencesThe pedigree of the studied family, and hematoxylin-eosin staining of colorectal adenocarcinoma or adenomas in

Updated on:February 20,2024

An antenna for detecting breast cancer

by David Bradley,InderscienceCredit: CC0 Public DomainBreast cancer is a common illness around the world. It is the most common invasive of cancers in women and affects around one in eight and r

Updated on: March 30,2024

An antenna for detecting breast cancer

by David Bradley,InderscienceCredit: CC0 Public DomainBreast cancer is a common illness around the world. It is the most common invasive of cancers in women and affects around one in eight and r

Updated on:March 30,2024